Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02082041 · ClinicalTrials.gov registry record
Measurement of Blood Perfusion in Response to Loading in Patients With Wounds
A clinical trial, sponsored by Michigan State University.
- Completed
- Registry status
- 41
- Enrollment target
NCT02082041: Completed study, sponsored by Michigan State University.
NCT02082041 is a clinical trial that has completed, run by Michigan State University. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02082041 has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to monitor the skin blood flow in the lower leg, with different levels and types of applied loads. These loads will not be placed over the patient's wound nor will they be higher than loads the skin normally experiences in daily activities. The results of this research will help investigators understand the development of pressure ulcers, commonly known as bedsores and stasis ulcers.
Primary Outcome
Skin perfusion will be measured as different loads are applied to the leg.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2013-06 |
| Est. Completion | 2016-03 |
What the finished NCT02082041 record still lists
NCT02082041 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02082041 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02082041 about?
NCT02082041 is a clinical study titled "Measurement of Blood Perfusion in Response to Loading in Patients With Wounds". The purpose of this study is to monitor the skin blood flow in the lower leg, with different levels and types of applied loads. These loads will not be placed over the patient's wound nor will they be higher than loads the skin normally experiences in daily activities. The results of this research w...
What is the current status of trial NCT02082041?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2013-06. Estimated completion is 2016-03.
Who is sponsoring clinical trial NCT02082041?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia